By now, most readers know that recently, Johnson & Johnson (J&J) was ordered to pay $417 million to a woman from East Los Angeles who claimed that she developed terminal ovarian cancer from using J&J’s talc powder products. The verdict included $70 million in compensatory damages and $347 million in punitive damages.
While this was the first such case to go to verdict against J&J in California — where hundreds of other similar cases are pending — this is not the first trial verdict nationally.…
Continue reading...
Litigation
Continue reading...
- Accutane Bowel Disease Lawsuit Results in $1.5M Verdict in Retrial
- AndroGel Stroke Lawsuit Filed Over Testosterone Gel Side Effects
- GranuFlo and NaturaLyte Use Identification Process Outlined By Judge
- Actos Trial Underway in Las Vegas Over Bladder Cancer in Two Users
- Benicar Lawsuit Filed Over Chronic Diarrhea, Intestinal Problems
- J&J Unit Hit With $3M Jury Verdict in Topamax Row (subscription required)
- Roche Defends Accutane Against New Evidence in NJ Retrial (subscription required)
- Zyprexa Fines Irrelevant in Actos Trial, Eli Lilly Says
Continue reading...
Litigation
Continue reading...
- J&J, Ethicon Sued Over Surgical Stapler Misfire (subscription required)
- GSK Can’t Shake Calif. County’s Avandia False Ad Claims (subscription required)
- Pradaxa Lawsuits Raise Questions Over Clinical Trial Data Accuracy
- Firms Kick Off Benicar Diarrhea Suits Against Daiichi (subscription required)
- Mirena Birth Control Lawsuit Filings Approach 1,000 Cases
- Boston Scientific Obtryx Sling Lawsuits Consolidated for Trial
- Zoloft False Ad Suit Time-Barred, Judge Finds (subscription required)
- J&J Hid Topamax Birth Defect Risks, Philly Jury Hears (subscription required)
- Total, Endo Units Hit With
Continue reading...
Litigation
Continue reading...
- Mich. Drug Companies Now Less Immune Under Tort Reform (subscription required)
- 9th Circ. To Reconsider Its Remand of Teva Painkiller Suit (subscription required)
- Medtronic Tells 10th Circ. Bone Device Suit is Preempted (subscription required)
- Unilever to Pay $10M Over Hair Loss Tied to Suave Product (subscription required)
- Expert Testimony Barred in Denture-Adhesive Mass Tort (subscription required)
- Roche Looks to Sink $2M Accutane Verdict on Appeal (subscription required)
- Pfizer Says 2nd Circ. Can’t Review Lipitor FCA Suit (subscription
Continue reading...
Litigation
Continue reading...
- Byetta Thyroid Cancer Lawsuit Centralization Request Filed with JPML
- MDL Arguments Over Centralization of Lipitor Diabetes Cases Postponed
- Top DOJ Atty Outline Pharma Fraud Enforcement (subscription required)
- Possible Sanctions for Takeda in Actos Bladder Cancer MDL (subscription required)
- Hydroxycut False Ad Claims Must Be Clarified, Judge Says (subscription required)
- GNC Hit with Suit Claiming Diet Pills Led to Liver Damage (subscription required)
- J&J Beats $258M Risperdal Verdict in Split La. High Court (subscription required)
- Calif. Court Reverses Preemption of Medtronic
Continue reading...
Litigation
Continue reading...
- NECC Fungal Meningitis Settlement May Result in $100M Payment
- MDL Consolidation for Lipitor Diabetes Lawsuits to be Considered Jan. 30
- J&J Risperdal Whistleblower Made Millions in Settlement
- Generic Fosamax Users Must Give More Details in MDL (subscription required)
- JPML Centralizes Glucosamine False Ad Suits (subscription required)
- Boehringer May Face More Sanctions in Pradaxa MDL (subscription required)
- FDA Permits Last-Resort Iclusig Use After Clinical Trial Deaths (subscription required)
- Proposed Rule – Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial
Continue reading...
Litigation
Continue reading...
- 3rd Circ. Doubts Jurisdiction In Generic-Fosamax Appeal (subscription required)
- Mirena IUD Lawsuit Discovery Continues in New Jersey and MDL
- Abbott Ordered to Produce “Overdue” Docs in Depakote Lawsuits
- J&J Fights Attys’ Pursuit of Confidential Risperdal Docs (subscription required)
- Pain-Pump Seller SJO Lied to Get $10M Policy, Insurer Says (subscription required)
- Stryker Inks 1st Settlements in NJ Hip Implant Suits (subscription required)
- Eli Lilly Defeats Soldier’s Cymbalta “Brain Zap” Suit (subscription required)
- 4th Circ. Questions Basis for Generic-Drug
Continue reading...
Litigation
Continue reading...
- High Court Denies Bid to Review Neurontin RICO Rulings (subscription required)
- Merck Settles Fosamax Jaw-Injury Claims for $28M (subscription required)
- Boehringer Fined $1M For Withholding Docs in MDL (subscription required)
- Expert Testimony Must be Backed By Science, Pa. Court Rules (subscription required)
- High Court Passes on Lupron Labeling Suit (subscription required)
- 1st Circ. Ends Takeda FCA Suit But Limits Scope of Ruling (subscription required)
- Medtronic Escapes Jury’s $18M Surgical Fire Verdict (subscription required)
- J&J Keeps Vaginal Mesh Suit Out of
Continue reading...
Litigation
Continue reading...
- Pamlab Can’t Bar Virtus’ Marketing In Unfair Competition Row (subscription required)
- Pa. Appeals Court Upholds GSK Win in Paxil Pregnancy Suit (subscription required)
- J&J Asks Pa. Court to Keep Risperdal Docs Under Seal (subscription required)
- Standing Issue Threatens 15 Zometa Suits in NJ (subscription required)
- 23andMe Hit with False Ad Suit Over DNA Tests (subscription required)
- Diageo Shells Out $81M to Settle Aussie, NZ Thalidomide Suits (subscription required)
- Generic-Reglan Suits Doomed by Catch-22, 6th Circ. Says (subscription required)
- J&J
Continue reading...
Litigation
Continue reading...
- Stryker Rejuvenate Lawsuits Filed by Nearly 1,000 Hip Patients Nationwide
- Novartis Can’t Apply NJ Punitives Cap in 3 Zometa Suits (subscription required)
- Pfizer Escapes FCA Suit Over Anti-Fungal Drug Promotions (subscription required)
- Gardasil Lawsuit Filed in France Over Side Effects of HPV Vaccine
- Judge Backs Jury Finding in J&J Body Powder Cancer Suit (subscription required)
- OxyElite Pro Class Action Filed Over False Advertising
- First Zoloft Trial in Federal MDL for Birth Defect Lawsuits to Begin Nov. 2014
- J&J Takes Innovative,
Continue reading...